GSK plc (GLAXF)
| Previous close | 21.14 |
| Open | 21.14 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 21.14 - 21.14 |
| 52-week range | 16.65 - 22.14 |
| Volume | |
| Avg. volume | 1,325 |
| Market cap | 88.378B |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | 15.54 |
| EPS (TTM) | 1.36 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | 0.75 (3.56%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
Investor's Business DailyGSK Stock Today: Buying An August Covered Call Boosts Your Return By This Much
A covered call strategy is one way to slightly reduce the risk on a long stock position while also generating some premium. Further upside in a covered call position in GSK stock is limited above the covered call strike. Let's look at how a covered call trade on GSK, formerly known as GlaxoSmithKline and based in the UK, might take shape.
Insider MonkeyGSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript
GSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript May 4, 2024 GSK plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Nick Stone: Hello everyone. Welcome to today’s call and webcast. The presentation was sent to our distribution list by email, and […]
Simply Wall St.GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
